Q32 Bio Inc. — Director's Dealing 2024

Sep 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-04-01

Reporting Person: Manke Isaac (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-01	Stock Option (Right to Buy)	$18	A	2627	Acquired	2034-03-31	Common Stock (2627)	Direct

Footnotes

F1: This option was granted in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive equity in lieu of cash compensation for services as a non-employee director of the Issuer.

F2: The shares underlying this option vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.